Fingerprint
Dive into the research topics where Experimental Therapeutics is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Co-phagocytosis by bispecific antibodies, a novel strategy for targeted degradation of soluble factors in the tumor microenvironment
Fan, Z., Feb 28 2026, In: Cancer Letters. 639, 218236.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Environmentally relevant levels of BDE-209 induces proteomic and phosphoproteomic reprogramming in murine melanoma cells
Ferrarini, M. G., Marchi, M., Moggio, E. L., Brum, H., Kugeratski, F. G., Batista, M., Oliveira Ribeiro, C. A. & Ávila, A. R., Mar 2026, In: Chemosphere. 397, 144857.Research output: Contribution to journal › Article › peer-review
Open Access -
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients
Castellino, R. C., Mumme, H., Franson, A., Yu, B., Robinson, H., Dhodapkar, K., Aguilera, D., Schniederjan, M., Keesari, R., He, Z., Bhasin, M., Priebe, W., Heimberger, A. B. & MacDonald, T. J., Feb 9 2026, In: JCI Insight. 11, 3Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations